Ace Therapeutics is an experienced company providing integrated solutions for innovative drug development in the preclinical stage of diabetes mellitus (DM) and its complications. We offer one-stop preclinical CRO services for global biotechnology and pharmaceutical clients, including target discovery, drug screening, and drug evaluation. Our vast experience allows us to effectively translate promising concepts into innovative therapeutic approaches, helping to expedite the drug development process and improve the efficiency of bringing new medications to the market.
More About UsWe provide customized in vivo and in vitro DM modeling services to accurately simulate the pathophysiology of this disease.
We provide high-quality drug development solutions, from target identification and lead optimization to preclinical testing, to help our clients navigate the intricate landscape of drug discovery.
We offer a comprehensive suite of R&D services to study diabetes and the diverse range of complications associated with this chronic condition.
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.